Inventor · disambiguated record
John D. Fikes
Also filed as: FIKES JOHN · FIKES JOHN D
9 granted patents·23 pending applications·406 citations·filing 1995–2016
91Inventor score
Top patents by PatentIndex Score
32 records- 0196US6602510B1HLA class I A2 tumor associated antigen peptides and vaccine compositionsEPIMMUNE INC·Filed 2000·Granted Aug 5, 2003·94 cites·11 claims
- 0294US6534482B1Expression vectors for stimulating an immune response and methods of using the sameEPIMMUNE INC·Filed 1999·Granted Mar 18, 2003·155 cites·4 claims
- 0392US10556943B2HLA-DR binding peptides and their usesMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Feb 11, 2020·16 cites·10 claims
- 0490US5750395ADNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptidesCYTEL CORP·Filed 1995·Granted May 12, 1998·73 cites·3 claims
- 0589US9913884B2HLA-A2 tumor associated antigen peptides and compositionsOSE PHARMA INT SA·Filed 2016·Granted Mar 13, 2018·13 cites·20 claims
- 0686US8007810B2HLA-A2 tumor associated antigen peptides and compositionsBIOTECH SYNERGY INC·Filed 2010·Granted Aug 30, 2011·11 cites·11 claims
- 0776US8741576B2Heteroclitic analogs and related methodsTANGRI SHABNAM·Filed 2002·Granted Jun 3, 2014·18 cites·12 claims
- 0876US6464980B1MAGE-1 c-terminal immunogenic peptidesEPIMMUNE INC·Filed 1996·Granted Oct 15, 2002·23 cites·5 claims
- 0972US9394350B2HLA-A2 tumor associated antigen peptides and compositionsFIKES JOHN D·Filed 2013·Granted Jul 19, 2016·3 cites·11 claims
- 1064US2008279924A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2007·Application pending·0 cites
- 1160US2003216342A1Expression vectors for stimulating an immune response and methods of using the sameFiled 2003·Application pending·0 cites
- 1260US2007098776A1HLA class I A2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2006·Application pending·0 cites
- 1360US2003216343A1Expression vectors for stimulating an immune response and methods of using the sameFiled 2003·Application pending·0 cites
- 1457US2010310640A1Hla-dr binding peptides and their usesKNUTSON KEITH L·Filed 2008·Application pending·0 cites
- 1555US2014377340A1Hla-dr binding peptides and their usesMAYO FOUNDATION·Filed 2014·Application pending·0 cites
- 1654US2011318408A1Hla class i a2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2011·Application pending·0 cites
- 1753US2003220285A1Expression vectors for stimulating an immune response and methods of using the sameFiled 2003·Application pending·0 cites
- 1852US2008274129A1Hla-A2 Tumor Associated Antigen Peptides and CompositionsFIKES JOHN D·Filed 2004·Application pending·0 cites
- 1951US2006094649A1Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositionsKEOGH ELISSA A·Filed 2003·Application pending·0 cites
- 2051US2012183598A1Hla-a2 tumor associated antigen peptides and compositionsFIKES JOHN D·Filed 2011·Application pending·0 cites
- 2150US2003203869A1Expression vectors for stimulating an immune response and methods of using the sameFiled 2003·Application pending·0 cites
- 2249US2005196403A1Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsFiled 2005·Application pending·0 cites
- 2348US2009169574A1Heteroclitic analogs and related methodsTANGRI SHABNAM·Filed 2007·Application pending·0 cites
- 2445US2004053822A1Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 2545US2004146519A1Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 2644US2007020327A1Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsFIKES JOHN·Filed 2006·Application pending·0 cites
- 2743US2004048790A1Inducing cellular immune responses to p53 using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 2843US2014147490A1Hla class i a2 tumor associated antigen peptides and vaccine compositionsFIKES JOHN D·Filed 2012·Application pending·0 cites
- 2943US2004121946A9Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 3042US2003224036A1Hla class I a2 tumor associated antigen peptides and vaccine compositionsFiled 2000·Application pending·0 cites
- 3142US2004037843A1Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositionsFiled 2000·Application pending·0 cites
- 3238US2006018915A1Heteroclitic analogs and related methodsISHIOKA GLENN·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John D. Fikes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →